McGuire, S. E., Lee, A. K., Cerne, J. Z., Munsell, M. F., Levy, L. B., Kudchadker, R. J., . . . Kuban, D. A. (2012). PSA RESPONSE TO NEOADJUVANT ANDROGEN DEPRIVATION THERAPY IS A STRONG INDEPENDENT PREDICTOR OF SURVIVAL IN HIGH-RISK PROSTATE CANCER IN THE DOSE-ESCALATED RADIATION THERAPY ERA.
Citação norma ChicagoMcGuire, Sean E., et al. PSA RESPONSE TO NEOADJUVANT ANDROGEN DEPRIVATION THERAPY IS A STRONG INDEPENDENT PREDICTOR OF SURVIVAL IN HIGH-RISK PROSTATE CANCER IN THE DOSE-ESCALATED RADIATION THERAPY ERA. 2012.
MLA CitationMcGuire, Sean E., et al. PSA RESPONSE TO NEOADJUVANT ANDROGEN DEPRIVATION THERAPY IS A STRONG INDEPENDENT PREDICTOR OF SURVIVAL IN HIGH-RISK PROSTATE CANCER IN THE DOSE-ESCALATED RADIATION THERAPY ERA. 2012.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.